Aline Alvarez aline_alvarezew@angelfire.com
: Please feel free to post the spam you get! :
Spammers Address: Aline Alvarez aline_alvarezew@angelfire.com
Spam Subject: Here's a hOt p|ay in m0tiOn..Investors
Spam Content:
( HOT NEWS FLASH TODAY - This One Is Moving ) Make Sure to Watch this one Monday morning and all next week! "A Premium Market Related Service" DGCP.OB Attn: Subscribers, Stockbrokers, Analysts & Investors Company: Diagnostic Corporation of America Symbol: DGCP.Ob Recent Price:$0.75 The company which has consistently revolutionized the medical industry has once again tossed its hat in to the international ring. In an effort to more accurately express the functions of the company in the medical industry we have changed our name to Diagnostic Corporation of America. As of last year we engaged our wholly-owned subsidiary Diagnostic Medical Partners to market and lease teleradiology equipment and medical testing. We are hoping to take advantage of the fragmented $12 billion MRI industry and establish independent testing facilities for the interpretation and collation of data, employing independent operators almost exclusively. Diagnostic Medical Partners is also set to be a world-wide distributor for an exciting alternative X-Ray project, Digital Motion XRay (DMX). We believe that in the coming years, DMX technology will revolutionize the radiology field. Among the greatest uses of DMX technology is in traffic accident-related cases. Diagnostic Medical Partners will lend DMX units to interested parties on a use lease basis. The lease will continue for a period of five years, after which time the facilities will own the equipment. With the rising cost of health care and the ever-expanding health market Diagnostic Corporation of America is well suited to lead the way into the 21st century with our expertise, our technological superiority over our competitors and our willingness to compete. Statements contained in this release that are not strictly historical are ``forward-looking'' statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
( HOT NEWS FLASH TODAY - This One Is Moving ) Make Sure to Watch this one Monday morning and all next week! "A Premium Market Related Service" DGCP.OB Attn: Subscribers, Stockbrokers, Analysts & Investors Company: Diagnostic Corporation of America Symbol: DGCP.Ob Recent Price:$0.75 The company which has consistently revolutionized the medical industry has once again tossed its hat in to the international ring. In an effort to more accurately express the functions of the company in the medical industry we have changed our name to Diagnostic Corporation of America. As of last year we engaged our wholly-owned subsidiary Diagnostic Medical Partners to market and lease teleradiology equipment and medical testing. We are hoping to take advantage of the fragmented $12 billion MRI industry and establish independent testing facilities for the interpretation and collation of data, employing independent operators almost exclusively. Diagnostic Medical Partners is also set to be a world-wide distributor for an exciting alternative X-Ray project, Digital Motion XRay (DMX). We believe that in the coming years, DMX technology will revolutionize the radiology field. Among the greatest uses of DMX technology is in traffic accident-related cases. Diagnostic Medical Partners will lend DMX units to interested parties on a use lease basis. The lease will continue for a period of five years, after which time the facilities will own the equipment. With the rising cost of health care and the ever-expanding health market Diagnostic Corporation of America is well suited to lead the way into the 21st century with our expertise, our technological superiority over our competitors and our willingness to compete. Statements contained in this release that are not strictly historical are ``forward-looking'' statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
posted by Scotty's Blog @ Sunday, April 24, 2005
0 Comments:
Post a Comment
<< Home